Galapagos

About:

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.

Website: http://www.glpg.com

Twitter/X: GalapagosNV

Top Investors: Gilead Sciences, Gilde Healthcare, University of Antwerp, Thuja Capital, Van Herk Ventures

Description:

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

Total Funding Amount:

$5.45B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Mechelen-bovelingen, Limburg, Belgium

Founded Date:

1999-01-01

Contact Email:

dpo(AT)glpg.com

Founders:

Dinko Valerio, Onno Stolpe, Rudi Pauwels

Number of Employees:

251-500

Last Funding Date:

2019-07-14

IPO Status:

Public

© 2025 bioDAO.ai